Martin Cranage

Summary

Affiliation: St George's
Country: UK

Publications

  1. doi request reprint Modern mucosal vaccines, adjuvants and microbicides
    Martin P Cranage
    Centre for Infection, Division of Cellular and Molecular Medicine, St George s University of London, London, SW17 6AU, UK
    Expert Rev Anti Infect Ther 7:21-3. 2009
  2. pmc Antibody responses after intravaginal immunisation with trimeric HIV-1 CN54 clade C gp140 in Carbopol gel are augmented by systemic priming or boosting with an adjuvanted formulation
    Martin P Cranage
    Centre for Infection and Immunity, Division of Clinical Sciences, St George s, University of London, Cranmer Terrace, London SW17 0RE, UK
    Vaccine 29:1421-30. 2011
  3. ncbi request reprint Carriers for the delivery of a vaccine against respiratory syncytial virus
    Martin Cranage
    Division of Cellular and Molecular Medicine, Centre for Infection, St George s, University of London, Cranmer Terrace, London, SW17 0RE, UK
    Expert Opin Biol Ther 5:939-52. 2005
  4. pmc Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel
    Martin Cranage
    Centre for Infection, Division of Cellular and Molecular Medicine, St George s University of London, London, United Kingdom
    PLoS Med 5:e157; discussion e157. 2008
  5. pmc Repeated vaginal administration of trimeric HIV-1 clade C gp140 induces serum and mucosal antibody responses
    M P Cranage
    Centre for Infection, Division of Cellular and Molecular Medicine, St George s University of London, London, UK
    Mucosal Immunol 3:57-68. 2010
  6. doi request reprint Colorectal microbicide design: triple combinations of reverse transcriptase inhibitors are optimal against HIV-1 in tissue explants
    Carolina Herrera
    Division of Clinical Sciences, Centre for Infection and Immunity, St George s University of London, UK
    AIDS 25:1971-9. 2011
  7. pmc Reverse transcriptase inhibitors as potential colorectal microbicides
    Carolina Herrera
    Division of Cellular and Molecular Medicine, St George s University of London, Cranmer Terrace, London SW17 0RE, United Kingdom
    Antimicrob Agents Chemother 53:1797-807. 2009
  8. doi request reprint Detection, quantification, and characterisation of HIV/SIV
    Neil Berry
    Division of Cellular and Molecular Medicine, Centre for Infection, St George s University of London, London, UK
    Methods Mol Biol 665:133-60. 2011
  9. ncbi request reprint Mucosal immunization with PLGA-microencapsulated DNA primes a SIV-specific CTL response revealed by boosting with cognate recombinant modified vaccinia virus Ankara
    Sally Sharpe
    Health Protection Agency, Porton Down, Salisbury, Wiltshire, SP4 0JG, UK
    Virology 313:13-21. 2003
  10. ncbi request reprint Single oral immunization with replication deficient recombinant adenovirus elicits long-lived transgene-specific cellular and humoral immune responses
    Sally Sharpe
    Centre for Applied Microbiology and Research, Salisbury SP4 0JG, United Kingdom
    Virology 293:210-6. 2002

Detail Information

Publications10

  1. doi request reprint Modern mucosal vaccines, adjuvants and microbicides
    Martin P Cranage
    Centre for Infection, Division of Cellular and Molecular Medicine, St George s University of London, London, SW17 6AU, UK
    Expert Rev Anti Infect Ther 7:21-3. 2009
    ..Protection of mucosal surfaces is likely to be particularly crucial to prevent infections with pathogens, such as HIV, that can be sequestered rapidly...
  2. pmc Antibody responses after intravaginal immunisation with trimeric HIV-1 CN54 clade C gp140 in Carbopol gel are augmented by systemic priming or boosting with an adjuvanted formulation
    Martin P Cranage
    Centre for Infection and Immunity, Division of Clinical Sciences, St George s, University of London, Cranmer Terrace, London SW17 0RE, UK
    Vaccine 29:1421-30. 2011
    ..Virus neutralising activity was detected against clade C and clade B HIV-1 envelopes but was restricted to highly neutralisation sensitive pseudoviruses...
  3. ncbi request reprint Carriers for the delivery of a vaccine against respiratory syncytial virus
    Martin Cranage
    Division of Cellular and Molecular Medicine, Centre for Infection, St George s, University of London, Cranmer Terrace, London, SW17 0RE, UK
    Expert Opin Biol Ther 5:939-52. 2005
    ....
  4. pmc Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel
    Martin Cranage
    Centre for Infection, Division of Cellular and Molecular Medicine, St George s University of London, London, United Kingdom
    PLoS Med 5:e157; discussion e157. 2008
    ....
  5. pmc Repeated vaginal administration of trimeric HIV-1 clade C gp140 induces serum and mucosal antibody responses
    M P Cranage
    Centre for Infection, Division of Cellular and Molecular Medicine, St George s University of London, London, UK
    Mucosal Immunol 3:57-68. 2010
    ..Our data prove the concept that repeated exposure of the female genital tract to HIV envelope can induce mucosally detectable antibody...
  6. doi request reprint Colorectal microbicide design: triple combinations of reverse transcriptase inhibitors are optimal against HIV-1 in tissue explants
    Carolina Herrera
    Division of Clinical Sciences, Centre for Infection and Immunity, St George s University of London, UK
    AIDS 25:1971-9. 2011
    ..As part of a strategy to develop an effective rectal microbicide, we performed an ex-vivo preclinical evaluation to determine the efficacy and limitation of multiple combinations of reverse transcriptase inhibitors (RTIs)...
  7. pmc Reverse transcriptase inhibitors as potential colorectal microbicides
    Carolina Herrera
    Division of Cellular and Molecular Medicine, St George s University of London, Cranmer Terrace, London SW17 0RE, United Kingdom
    Antimicrob Agents Chemother 53:1797-807. 2009
    ..These findings may have important implications for the rational design of effective rectal microbicides...
  8. doi request reprint Detection, quantification, and characterisation of HIV/SIV
    Neil Berry
    Division of Cellular and Molecular Medicine, Centre for Infection, St George s University of London, London, UK
    Methods Mol Biol 665:133-60. 2011
    ..Representative nucleic acid testing protocols including nested PCR, RT-PCR, and quantitative real-time PCR, as well as protocols based on virus infectivity, are presented...
  9. ncbi request reprint Mucosal immunization with PLGA-microencapsulated DNA primes a SIV-specific CTL response revealed by boosting with cognate recombinant modified vaccinia virus Ankara
    Sally Sharpe
    Health Protection Agency, Porton Down, Salisbury, Wiltshire, SP4 0JG, UK
    Virology 313:13-21. 2003
    ..Analysis of lymphoid tissues revealed a disseminated CTL response in peripheral and regional lymph nodes but not the spleen of both mucosally primed animals...
  10. ncbi request reprint Single oral immunization with replication deficient recombinant adenovirus elicits long-lived transgene-specific cellular and humoral immune responses
    Sally Sharpe
    Centre for Applied Microbiology and Research, Salisbury SP4 0JG, United Kingdom
    Virology 293:210-6. 2002
    ....